What are the role of the antivirals lopinavirritonavir and ... | 疾病管制署傳染病
TheNIHPanelforCOVID-19TreatmentGuidelinesrecommendagainsttheuseoflopinavir/ritonavirorotherHIVproteaseinhibitors,owingtounfavorable ...
The NIH Panel for COVID-19 Treatment Guidelines recommend against the use of lopinavir/ritonavir or other HIV protease inhibitors, owing to unfavorable ...
Kaletra COVID Kaletra COVID a型肝炎疫苗發燒 a型肝炎疫苗第二劑 傷寒檢查是什麼 Lassa Fever virus 日本腦炎後遺症 Severe fever with thrombocytopenia syndrome 貝樂克降價 痲瘋病院的世界心得
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with ... | 疾病管制署傳染病
由 B Cao 著作 · 2020 · 被引用 4280 次 — In hospitalized adult patients with severe Covid-19, no benefit was observed with lopinavir–ritonavir treatment beyond standard care. Read More
Lopinavir–ritonavir in patients admitted to ... | 疾病管制署傳染病
由 PW Horby 著作 · 2020 · 被引用 132 次 — Lopinavir–ritonavir has been proposed as a treatment for COVID-19 on the basis of in vitro activity, preclinical studies, and observational ... Read More
No Benefit for Lopinavir–Ritonavir in Severe COVID | 疾病管制署傳染病
據新英格蘭醫學期刊的一項臨床試驗，在COVID-19的住院患者中，使用HIV治療藥物Lopinavir-Ritonavir並未加速恢復或降低死亡率。這項研究中，199 ... Read More
Kaletra Again Fails for Moderate-to | 疾病管制署傳染病
2020年10月6日 — Lopinavir-ritonavir (Kaletra), a protease inhibitor mainly used for HIV, did not reduce mortality or speed recovery from COVID-19, Britain's large ... Read More
Kaletra for COVID | 疾病管制署傳染病
2020年7月10日 — Heart rate dropped below 60 bpm for more than 24 hours in nine out of 41 SARS-CoV-2-infected patients in the ICU who were on lopinavir/ ... Read More
What are the role of the antivirals lopinavirritonavir and ... | 疾病管制署傳染病
The NIH Panel for COVID-19 Treatment Guidelines recommend against the use of lopinavir/ritonavir or other HIV protease inhibitors, owing to unfavorable ... Read More
Kaletra—from HIV to SARS to COVID-19 | 疾病管制署傳染病
由 SR Hosein 著作 — Kaletra—from HIV to SARS to COVID-19 ... One of the medicines that has been undergoing extensive testing in people with COVID-19 is a fixed-dose formulation of ... Read More
LopinavirRitonavir and Other HIV Protease Inhibitors | 疾病管制署傳染病
2021年2月11日 — Lopinavir/ritonavir and darunavir/cobicistat have been studied in patients with COVID-19. The clinical trials discussed below have not ... Read More
COVID outpatients don't benefit from hydroxychloroquine ... | 疾病管制署傳染病
2021年4月22日 — A randomized, controlled trial of 685 adult COVID-19 outpatients in Brazil ... lopinavir-ritonavir significantly lowered rates of coronavirus–related ... Read More
相關資訊整理
愛滋病用藥可否自行停藥？(公關室題目)
【愛滋病用藥可否自行停藥？(公關室題目)】絕對不可以自行停藥！感染者一旦開始服藥，必須長期規則服用抗愛滋病毒藥物，若服...